ScholarIQanswers from OpenAlex
Canadian VIGOUR Centre
InstitutionResearch output, impact & collaborations
Canadian VIGOUR Centre is a institution indexed in ScholarIQ from OpenAlex.
What is known about Canadian VIGOUR Centre?
ScholarIQrecord summary
Canadian VIGOUR Centre is a research organisation in Edmonton, CA. OpenAlex records 1,256 works and 84,548 citations for it. 188 researchers list it as their most recent affiliation.
How many works does Canadian VIGOUR Centre have?
ScholarIQindexed works
Canadian VIGOUR Centre has 1,256 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Canadian VIGOUR Centre have?
ScholarIQcitation count
Canadian VIGOUR Centre has 84,548 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Canadian VIGOUR Centre?
ScholarIQresearcher count
Canadian VIGOUR Centre has 188 researchers in the ScholarIQ index.
What is the average h-index at Canadian VIGOUR Centre?
ScholarIQavg h-index
Canadian VIGOUR Centre has an average h-index of 118 in OpenAlex.
What is the ROR of Canadian VIGOUR Centre?
ScholarIQror
The ROR for Canadian VIGOUR Centre is on the source record.
What is the OpenAlex record for Canadian VIGOUR Centre?
ScholarIQopenalex
The OpenAlex for Canadian VIGOUR Centre is on the source record.
Who are the most-cited researchers behind Canadian VIGOUR Centre?
ScholarIQtop researchers by citations
What are the most-cited papers on Canadian VIGOUR Centre?
ScholarIQmost cited works
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
Elliott M. Antman, Daniel T. Anbe, Paul W. Armstrong, Eric Bates, Lee A. Green, Mary M. Hand, Judith S. Hochman, Harlan M. Krumholz, Frederick G. Kushner, Gervasio A. Lamas, Charles J. Mullany, Joseph P. Ornato, David L. Pearle, Michael A. Sloan, Sidney C. Smith, Elliott M. Antman, Sidney C. Smith, Joseph S. Alpert, Jeffrey L. Anderson, David P. Faxon, Valentı́n Fuster, Raymond J. Gibbons, Gabriel Gregoratos, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Alice K. Jacobs, Joseph P. Ornato
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong, John B. Buse, Samuel S. Engel, Jyotsna Garg, Robert Josse, Keith D. Kaufman, Joerg Koglin, Scott Korn, John M. Lachin, Darren K. McGuire, Michael Pencina, Eberhard Standl, Peter P. Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D. Peterson, Rury R. Holman
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
Elliott M. Antman, Mary M. Hand, Paul W. Armstrong, Eric Bates, Lee A. Green, Lakshmi Halasyamani, Judith S. Hochman, Harlan M. Krumholz, Gervasio A. Lamas, Charles J. Mullany, David L. Pearle, Michael A. Sloan, Sidney C. Smith, Elliott M. Antman, Daniel T. Anbe, Paul W. Armstrong, Eric Bates, Lee A. Green, Mary M. Hand, Judith S. Hochman, Harlan M. Krumholz, Frederick G. Kushner, Gervasio A. Lamas, Charles J. Mullany, Joseph P. Ornato, David L. Pearle, Michael A. Sloan, Sidney C. Smith, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, Jonathan L. Halperin, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, Richard L. Page, Bárbara Riegel, Lynn G. Tarkington, Clyde W. Yancy
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
Elliott M. Antman, Daniel T. Anbe, Paul W. Armstrong, Eric Bates, Lee A. Green, Mary M. Hand, Judith S. Hochman, Harlan M. Krumholz, Frederick G. Kushner, Gervasio A. Lamas, Charles J. Mullany, Joseph P. Ornato, David L. Pearle, Michael A. Sloan, Sidney C. Smith, Joseph S. Alpert, Jeffrey L. Anderson, David P. Faxon, Valentı́n Fuster, Raymond J. Gibbons, Gabriel Gregoratos, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Alice K. Jacobs, Joseph P. Ornato
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
Milton Packer, Philip A. Poole‐Wilson, Paul W. Armstrong, John G.F. Cleland, John D. Horowitz, Barry M. Massie, Lars Rydén, Kristian Thygesen, Barry F. Uretsky
How much of the research on Canadian VIGOUR Centre is open access?
ScholarIQopen access share
25%OPEN ACCESS